BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35536533)

  • 41. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reevaluation of FDG-PET/CT in patients with hoarseness caused by vocal cord palsy.
    Minamimoto R; Kubota K; Morooka M; Ito K; Mitsumoto T; Okasaki M; Shimbo T; Tayama N
    Ann Nucl Med; 2012 Jun; 26(5):405-11. PubMed ID: 22427268
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Wu X; Huang Y; Li Y; Wang Q; Wang H; Jiang L
    Ann Nucl Med; 2019 Sep; 33(9):647-656. PubMed ID: 31165974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Significance of Incidental Focal
    Lim CH; Hyun SH; Moon SH; Cho YS; Choe YS; Lee KH; Kim BT; Choi JY
    Nucl Med Mol Imaging; 2017 Sep; 51(3):247-251. PubMed ID: 28878851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
    Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
    Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
    van den Bosch S; Dijkema T; Philippens MEP; Terhaard CHJ; Hoebers FJP; Kaanders JHAM; Oyen WJG
    Radiother Oncol; 2019 Jan; 130():39-45. PubMed ID: 30005954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Qualitative analysis of spinal intramedullary lesions using PET/CT.
    Naito K; Yamagata T; Arima H; Abe J; Tsuyuguchi N; Ohata K; Takami T
    J Neurosurg Spine; 2015 Nov; 23(5):613-619. PubMed ID: 26230418
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Su W; Zhao S; Chen Y; Zuo C; Cui B; Wang M; Ren F
    Abdom Radiol (NY); 2020 Mar; 45(3):743-749. PubMed ID: 31907569
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Song L; Han S; Zhang W; Jiang L
    Skeletal Radiol; 2020 Nov; 49(11):1737-1745. PubMed ID: 32444915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
    Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
    Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic changes in breast cancer on dual-time-point
    Kim HO; Kim BS; Kang SY; Bang JI; An J; Kim JH; Yoon HJ
    Ann Nucl Med; 2020 Dec; 34(12):942-951. PubMed ID: 32974848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physiological ¹⁸F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients?
    Amin A; Rosenbaum SJ; Bockisch A
    J Neurooncol; 2012 May; 107(3):609-15. PubMed ID: 22249691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.
    Malladi A; Viner M; Jackson T; Mercier G; Subramaniam RM
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):169-75. PubMed ID: 23551774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Prostate Cancer Glucose Metabolism Detected by
    Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
    Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist.
    Albano D; Bosio G; Tomasini D; Bonù M; Giubbini R; Bertagna F
    Asia Pac J Clin Oncol; 2020 Oct; 16(5):e207-e215. PubMed ID: 32762133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
    Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
    AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
    J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.